Half-year report · Q2
9218.TEDINET S100WJ85
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.0bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥5.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥278m | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | −¥102m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥255m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥39m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥152m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥256m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥152m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥156m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥30m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥203m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥156m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | −¥203m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥4.7bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥910m | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥910m | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥238m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥271m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥29m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥262m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥184m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥15.07 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.92 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.08 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥14.77 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 27.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-01-01 → 2025-06-30 | ¥86m |
| Otherother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥60m |
| Otherother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥25m |
| Otherother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥4m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥278m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥131m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥750,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥421m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥26m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥556m |
| Otherother segments | revenue | 2024-01-01 → 2024-06-30 | ¥136m |
| Otherother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥111m |
| Otherother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥25m |
| Otherother segments | segment profit | 2024-01-01 → 2024-06-30 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥577m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥109m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥350,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥330m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥26m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥476m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 532
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)かがやき監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)奥村 隆志 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)牛丸 智詞 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2275812000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 3023829000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5134775000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -151856000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 255050000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 39438000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -202999000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 156121000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -29779000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -202999000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 156121000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -29779000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 1110736000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 1459376000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1294956000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 4508468000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 4657244000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 4625649000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -20.08 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 15.07 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -2.92 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 14.77 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.202 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.271 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.237 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 28931000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 238006000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 270515000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1946310000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -261505000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2146958000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 2059418000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -183537000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 2079266000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1055754000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 909502000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1116537000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10391300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10391300 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10391300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10391300 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 3706000000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3566 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |